Literature DB >> 21285072

Primary prevention of stroke: blood pressure, lipids, and heart failure.

Matthias Endres1, Peter U Heuschmann, Ulrich Laufs, Antoine M Hakim.   

Abstract

Stroke contributes significantly to morbidity, mortality, and disability worldwide. Despite the successes accomplished in the acute treatment and rehabilitation of stroke, the global burden of this disease can only be tackled with co-ordinated approaches for primary prevention. Stroke is a heterogeneous disease and the contribution of individual risk factors to its occurrence estimated by population attributable risk differs from coronary heart disease. Here, we review evidence to demonstrate the prominent role of elevated blood pressure (BP) and heart disease on risk of stroke, while the influence of lipids on stroke is less clear; we also demonstrate that stroke is an important complication of heart failure. Current approaches to primary preventive action emphasize the need to target the absolute risk of cardiovascular diseases rather than individual risk factors. Lifestyle interventions serve as a basis for primary prevention of cardiovascular diseases. It is estimated that 70% of strokes are potentially preventable by lifestyle modification but prospective evidence is needed to support these hypotheses derived from epidemiological studies. Different strategies for drug interventions in primary prevention are discussed, including the polypill strategy. Additional measures are needed for the primary prevention of stroke which focus on BP, chronic heart failure, and possibly lipids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285072     DOI: 10.1093/eurheartj/ehq472

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  27 in total

Review 1.  Impact of particulate matter exposition on the risk of ischemic stroke: epidemiologic evidence and putative mechanisms.

Authors:  Daniel von Bornstädt; Alexander Kunz; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-04       Impact factor: 6.200

Review 2.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

3.  Circulating fetuin-A and risk of ischemic stroke in women.

Authors:  Monik C Jiménez; Qi Sun; Markus Schürks; Frank B Hu; Joann E Manson; Kathryn M Rexrode
Journal:  Clin Chem       Date:  2013-10-29       Impact factor: 8.327

4.  Improving adherence with medication: a selective literature review based on the example of hypertension treatment.

Authors:  Jan Matthes; Christian Albus
Journal:  Dtsch Arztebl Int       Date:  2014-01-24       Impact factor: 5.594

Review 5.  The impact of cerebral microbleeds on intracerebral hemorrhage and poor functional outcome of acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis.

Authors:  Shuang Wang; Yan Lv; Xin Zheng; Jing Qiu; Hui-Sheng Chen
Journal:  J Neurol       Date:  2016-11-24       Impact factor: 4.849

6.  [Stroke - lifestyle and environment].

Authors:  L M Gerischer; A Flöel; M Endres
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 7.  [Physical training for neurological and mental diseases].

Authors:  K Henkel; C D Reimers; G Knapp; F Schneider
Journal:  Nervenarzt       Date:  2014-12       Impact factor: 1.214

8.  Pharmacologically increasing collateral perfusion during acute stroke using a carboxyhemoglobin gas transfer agent (Sanguinate™) in spontaneously hypertensive rats.

Authors:  Marilyn J Cipolla; Italo Linfante; Abe Abuchowski; Ronald Jubin; Siu-Lung Chan
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-24       Impact factor: 6.200

9.  [Primary and secondary prevention of stroke].

Authors:  F Masuhr; M A Busch
Journal:  Internist (Berl)       Date:  2012-12       Impact factor: 0.743

10.  Effect of hypertension and peroxynitrite decomposition with FeTMPyP on CBF and stroke outcome.

Authors:  Marilyn J Cipolla; Julie G Sweet; Siu-Lung Chan
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.